Article
AML1-ETO reprograms hematopoietic cell fate by downregulating<i>scl</i>expression
21 Dec 2007
Abstract excerpt
AML1-ETO is one of the most common chromosomal translocation products associated with acute myelogenous leukemia (AML). Patients carrying the AML1-ETO fusion gene exhibit an accumulation of granulocyte precursors in the bone marrow and the blood. Here, we describe a transgenic zebrafish line that enables inducible expression of the human AML1-ETO oncogene. Induced AML1-ETO expression in embryonic zebrafish causes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
